For research use only. We do not sell to patients.
MLi-2
CAS No. : 1627091-47-7
Biological Activity：MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease.
Research Area：Neurological Disease
Targets：LRRK2
Related Screening Libraries:Bioactive Compound Library Plus;Kinase Inhibitor Library;Autophagy Compound Library;Orally Active Compound Library;Chemical Probe Library;Anti-Parkinson’s Disease Compound Library;Neurodegenerative Disease-related Compound Library;Targeted Diversity Library;
Related Small Molecules:LRRK2 inhibitor 1;CZC-25146;LRRK2-IN-2;GNE0877;IKK 16;LRRK2-IN-1;EB-42486;XL01126;PFE-360;GSK2646264;PF-06454589;LRRK2-IN-5;PF-06456384 trihydrochloride;PF-06455943;LRRK2-IN-4;JH-II-127;GSK2578215A;LRRK2-IN-6;GNE-9605;GNE-7915;CZC-54252;Indazole;HG-10-102-01;PF-06447475
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
